Bill Text: IL HB0702 | 2013-2014 | 98th General Assembly | Enrolled

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Environmental Protection Act. Makes a technical change in a Section concerning the short title.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Passed) 2013-08-16 - Public Act . . . . . . . . . 98-0366 [HB0702 Detail]

Download: Illinois-2013-HB0702-Enrolled.html



HB0702 EnrolledLRB098 03526 JDS 33541 b
1 AN ACT concerning safety.
2 Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4 Section 5. The Environmental Protection Act is amended by
5changing Section 3.360 as follows:
6 (415 ILCS 5/3.360) (was 415 ILCS 5/3.84)
7 Sec. 3.360. Potentially infectious medical waste.
8 (a) "Potentially infectious medical waste" means the
9following types of waste generated in connection with the
10diagnosis, treatment (i.e., provision of medical services), or
11immunization of human beings or animals; research pertaining to
12the provision of medical services; or the production or testing
13of biologicals:
14 (1) Cultures and stocks. This waste shall include but
15 not be limited to cultures and stocks of agents infectious
16 to humans, and associated biologicals; cultures from
17 medical or pathological laboratories; cultures and stocks
18 of infectious agents from research and industrial
19 laboratories; wastes from the production of biologicals;
20 discarded live or attenuated vaccines; or culture dishes
21 and devices used to transfer, inoculate, or mix cultures.
22 (2) Human pathological wastes. This waste shall
23 include tissue, organs, and body parts (except teeth and

HB0702 Enrolled- 2 -LRB098 03526 JDS 33541 b
1 the contiguous structures of bone and gum); body fluids
2 that are removed during surgery, autopsy, or other medical
3 procedures; or specimens of body fluids and their
4 containers.
5 (3) Human blood and blood products. This waste shall
6 include discarded human blood, blood components (e.g.,
7 serum and plasma), or saturated material containing free
8 flowing blood or blood components.
9 (4) Used sharps. This waste shall include but not be
10 limited to discarded sharps used in animal or human patient
11 care, medical research, or clinical or pharmaceutical
12 laboratories; hypodermic, intravenous, or other medical
13 needles; hypodermic or intravenous syringes; Pasteur
14 pipettes; scalpel blades; or blood vials. This waste shall
15 also include but not be limited to other types of broken or
16 unbroken glass (including slides and cover slips) in
17 contact with infectious agents.
18 (5) Animal waste. Animal waste means discarded
19 materials, including carcasses, body parts, body fluids,
20 blood, or bedding originating from animals inoculated
21 during research, production of biologicals, or
22 pharmaceutical testing with agents infectious to humans.
23 (6) Isolation waste. This waste shall include
24 discarded materials contaminated with blood, excretions,
25 exudates, and secretions from humans that are isolated to
26 protect others from highly communicable diseases. "Highly

HB0702 Enrolled- 3 -LRB098 03526 JDS 33541 b
1 communicable diseases" means those diseases identified by
2 the Board in rules adopted under subsection (e) of Section
3 56.2 of this Act.
4 (7) Unused sharps. This waste shall include but not be
5 limited to the following unused, discarded sharps:
6 hypodermic, intravenous, or other needles; hypodermic or
7 intravenous syringes; or scalpel blades.
8 (b) Potentially infectious medical waste does not include:
9 (1) waste generated as general household waste;
10 (2) waste (except for sharps) for which the infectious
11 potential has been eliminated by treatment; or
12 (3) sharps that meet both of the following conditions:
13 (A) the infectious potential has been eliminated
14 from the sharps by treatment; and
15 (B) the sharps are rendered unrecognizable by
16 treatment; or .
17 (4) sharps that are managed in accordance with the
18 following requirements:
19 (A) the infectious potential is eliminated from
20 the sharps by treatment at a facility that is permitted
21 by the Agency for the treatment of potentially
22 infectious medical waste;
23 (B) the sharps are certified by the treatment
24 facility as non-special waste in accordance with
25 Section 22.48 of this Act;
26 (C) the sharps are packaged at the treatment

HB0702 Enrolled- 4 -LRB098 03526 JDS 33541 b
1 facility the same as required under Board rules for
2 potentially infectious medical waste;
3 (D) the sharps are transported under the custody of
4 the treatment facility to a landfill permitted by the
5 Agency under Section 21 of this Act to accept municipal
6 waste for disposal; and
7 (E) the activities in subparagraphs (A) through
8 (D) of this paragraph (4) are authorized in, and
9 conducted in accordance with, a permit issued by the
10 Agency to the treatment facility.
11(Source: P.A. 92-574, eff. 6-26-02.)
feedback